"10.1371_journal.pone.0080305","plos one","2013-12-06T00:00:00Z","Florence Meyer-Losic; Simon P Newman; Joanna M Day; Michael J Reed; Philip G Kasprzyk; Atul Purohit; Paul A Foster","IPSEN Innovation, IPSEN, Paris, France; Oncology Drug Discovery and Womens Health Group, Imperial College London, London, United Kingdom; Ipsen Biomeasure, IPSEN, Milford, Massachusetts, United States of America; Centre for Endocrinology, Diabetes and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom","â€  Deceased.","The authors have read the journals policy and have the following conflicts: Florence Meyer-Losic and Philip Kasprzyk are employees of IPSEN. Atul Purohit is a consultant for IPSEN. The authors declare Sterix Ltd. as a commercial funder, funding the employment of Dr. Simon Newman, Dr. Joanna Day, and Dr. Paul Foster. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Florence Meyer-Losic","FML",7,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
